| Cohen's Fashion Optical | |
|
1112 Green Acres Mall, Valley Stream, NY 11581-1536 | |
| (516) 825-4900 | |
| (516) 561-5905 |
| Full Name | Cohen's Fashion Optical |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 1112 Green Acres Mall, Valley Stream, New York |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184754624 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | NY 003561-2 (New York) | Primary |
| Provider Name | Samuel Munonyedi |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1952357527 PECOS PAC ID: 9931119534 Enrollment ID: I20060426000865 |
News Archive
AngioDynamics announced today the launch of a new Morpheus® SMART PICC bedside insertion kit and new 5 French Dual Lumen Peripherally Inserted Central Catheter (PICC) as part of the continued growth of its Morpheus SMART PICC line.
As delegates gathered for the XIX International AIDS Conference (AIDS 2012) this week in Washington, D.C., "supporters of the 2010 Vienna Declaration, which urges governments to write evidence-based drug policies," launched an ad campaign calling on U.S. President Barack Obama and Republican presidential candidate Mitt Romney "to stop the spread of AIDS by ending the so-called 'war on drugs,'" the Globe and Mail reports.
Though H1N1 (swine flu) activity worldwide has slowed, the potential of a new wave of infections in the northern hemisphere in late winter or early spring remains viable, Keiji Fukuda, the WHO's top flu expert, said Monday at the start of the WHO's weeklong executive board meeting, Reuters reports.
"Good morning, doctor, I am here for my gene editing appointment." In the future, could this be a greeting heard in physician offices around the world? With the introduction of CRISPR technology, genetic material can now be more easily and precisely edited, even creating changes that can subsequently be inherited by offspring.
Mersana Therapeutics, a platform-based cancer therapeutics company, today announced that it has initiated a Phase 1 clinical trial to study the safety and pharmacokinetics of XMT-1107 in patients with refractory advanced solid tumors. XMT-1107 is a novel anti-angiogenic fumagillin analog that employs Mersana's Fleximer platform. Mersana's XMT-1001, a conjugate of Fleximer and camptothecin, is currently completing a Phase 1 study.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Cohen's Fashion Optical 1112 Green Acres Mall, Valley Stream, NY 11581-1536 Ph: (516) 825-4900 | Cohen's Fashion Optical 1112 Green Acres Mall, Valley Stream, NY 11581-1536 Ph: (516) 825-4900 |
News Archive
AngioDynamics announced today the launch of a new Morpheus® SMART PICC bedside insertion kit and new 5 French Dual Lumen Peripherally Inserted Central Catheter (PICC) as part of the continued growth of its Morpheus SMART PICC line.
As delegates gathered for the XIX International AIDS Conference (AIDS 2012) this week in Washington, D.C., "supporters of the 2010 Vienna Declaration, which urges governments to write evidence-based drug policies," launched an ad campaign calling on U.S. President Barack Obama and Republican presidential candidate Mitt Romney "to stop the spread of AIDS by ending the so-called 'war on drugs,'" the Globe and Mail reports.
Though H1N1 (swine flu) activity worldwide has slowed, the potential of a new wave of infections in the northern hemisphere in late winter or early spring remains viable, Keiji Fukuda, the WHO's top flu expert, said Monday at the start of the WHO's weeklong executive board meeting, Reuters reports.
"Good morning, doctor, I am here for my gene editing appointment." In the future, could this be a greeting heard in physician offices around the world? With the introduction of CRISPR technology, genetic material can now be more easily and precisely edited, even creating changes that can subsequently be inherited by offspring.
Mersana Therapeutics, a platform-based cancer therapeutics company, today announced that it has initiated a Phase 1 clinical trial to study the safety and pharmacokinetics of XMT-1107 in patients with refractory advanced solid tumors. XMT-1107 is a novel anti-angiogenic fumagillin analog that employs Mersana's Fleximer platform. Mersana's XMT-1001, a conjugate of Fleximer and camptothecin, is currently completing a Phase 1 study.
› Verified 5 days ago
South Shore Opticians Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1033 Green Acres Mall, Valley Stream, NY 11581 Phone: 516-825-8990 Fax: 516-872-2702 | |
Valley Stream Optometric Services Pc Optometrist Medicare: Medicare Enrolled Practice Location: 5 Sunrise Plz Ste 101, Valley Stream, NY 11580 Phone: 516-825-7455 Fax: 516-825-1494 | |
Brenda Liang, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 10 E Merrick Rd Ste 201, Valley Stream, NY 11580 Phone: 516-825-7455 Fax: 516-825-1494 | |
Dr. Arthur Michael Purvin, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 10 E. Merrick Rd., Suite 201, Valley Stream, NY 11580 Phone: 516-825-7455 Fax: 516-825-1494 | |
Dr. Mark Joel Bashover, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 845 Newburg Ave, Valley Stream, NY 11581 Phone: 516-791-8254 Fax: 516-791-8254 | |
Howard Eyecare Optometrist Medicare: Not Enrolled in Medicare Practice Location: 129 Rockaway Ave, Valley Stream, NY 11580 Phone: 516-561-8545 |